138 related articles for article (PubMed ID: 7699460)
1. Validation of 4-[fluorine-18]fluoro-3-iodobenzylguanidine as a positron-emitting analog of MIBG.
Vaidyanathan G; Affleck DJ; Zalutsky MR
J Nucl Med; 1995 Apr; 36(4):644-50. PubMed ID: 7699460
[TBL] [Abstract][Full Text] [Related]
2. No-carrier-added iodine-131-FIBG: evaluation of an MIBG analog.
Vaidyanathan G; Zhao XG; Strickland DK; Zalutsky MR
J Nucl Med; 1997 Feb; 38(2):330-4. PubMed ID: 9025764
[TBL] [Abstract][Full Text] [Related]
3. (4-[18F]fluoro-3-iodobenzyl)guanidine, a potential MIBG analogue for positron emission tomography.
Vaidyanathan G; Affleck DJ; Zalutsky MR
J Med Chem; 1994 Oct; 37(21):3655-62. PubMed ID: 7932592
[TBL] [Abstract][Full Text] [Related]
4. 3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells.
Vaidyanathan G; Zhao XG; Larsen RH; Zalutsky MR
Br J Cancer; 1997; 76(2):226-33. PubMed ID: 9231923
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo studies with no-carrier added radioiodinated MIBG.
Franceschini R; Pecorale A; Chinol M; Calcagni ML; Servidei T; Riccardi R; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):72-7. PubMed ID: 9002755
[TBL] [Abstract][Full Text] [Related]
6. Potential and practical adrenomedullary PET radiopharmaceuticals as an alternative to m-iodobenzylguanidine: m-(omega-[18F]fluoroalkyl)benzylguanidines.
Lee BC; Paik JY; Chi DY; Lee KH; Choe YS
Bioconjug Chem; 2004; 15(1):104-11. PubMed ID: 14733589
[TBL] [Abstract][Full Text] [Related]
7. Radiolabeled (4-Fluoro-3-Iodobenzyl)Guanidine Improves Imaging and Targeted Radionuclide Therapy of Norepinephrine Transporter-Expressing Tumors.
Yamaguchi A; Hanaoka H; Higuchi T; Tsushima Y
J Nucl Med; 2018 May; 59(5):815-821. PubMed ID: 29217738
[No Abstract] [Full Text] [Related]
8. Synthesis and evaluation of 4-[18F]fluoropropoxy-3-iodobenzylguanidine ([18F]FPOIBG): A novel 18F-labeled analogue of MIBG.
Vaidyanathan G; McDougald D; Koumarianou E; Choi J; Hens M; Zalutsky MR
Nucl Med Biol; 2015 Aug; 42(8):673-84. PubMed ID: 25956997
[TBL] [Abstract][Full Text] [Related]
9. Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells.
Smets LA; Loesberg C; Janssen M; Metwally EA; Huiskamp R
Cancer Res; 1989 Jun; 49(11):2941-4. PubMed ID: 2720653
[TBL] [Abstract][Full Text] [Related]
10. Specific uptake of m-[125I]iodobenzylguanidine in the human neuroblastoma cell line SK-N-SH.
Buck J; Bruchelt G; Girgert R; Treuner J; Niethammer D
Cancer Res; 1985 Dec; 45(12 Pt 1):6366-70. PubMed ID: 3864530
[TBL] [Abstract][Full Text] [Related]
11. Effect of specific activity on cardiac uptake of iodine-123-MIBG.
Farahati J; Bier D; Scheubeck M; Lassmann M; Schelper LF; Grelle I; Hanscheid H; Biko J; Graefe KH; Reiners C
J Nucl Med; 1997 Mar; 38(3):447-51. PubMed ID: 9074536
[TBL] [Abstract][Full Text] [Related]
12. No-carrier-added iodine-131-MIBG: evaluation of a therapeutic preparation.
Mairs RJ; Cunningham SH; Russell J; Armour A; Owens J; McKellar K; Gaze MN
J Nucl Med; 1995 Jun; 36(6):1088-95. PubMed ID: 7769433
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effect of m-[131I]- and m-[125I]iodobenzylguanidine on neuroblastoma multicellular tumor spheroids of different sizes.
Weber W; Weber J; Senekowitsch-Schmidtke R
Cancer Res; 1996 Dec; 56(23):5428-34. PubMed ID: 8968097
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic effects of m-[131I]- and m-[125I]iodobenzylguanidine on the human neuroblastoma cell lines SK-N-SH and SK-N-LO.
Bruchelt G; Girgert R; Buck J; Wolburg H; Niethammer D; Treuner J
Cancer Res; 1988 Jun; 48(11):2993-7. PubMed ID: 3365688
[TBL] [Abstract][Full Text] [Related]
15. Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo.
Heiss P; Mayer S; Herz M; Wester HJ; Schwaiger M; Senekowitsch-Schmidtke R
J Nucl Med; 1999 Aug; 40(8):1367-73. PubMed ID: 10450690
[TBL] [Abstract][Full Text] [Related]
16. SIMS microscopy imaging of the intratumor biodistribution of metaiodobenzylguanidine in the human SK-N-SH neuroblastoma cell line xenografted into nude mice.
Clerc J; Halpern S; Fourré C; Omri F; Briançon C; Jeusset J; Fragu P
J Nucl Med; 1993 Sep; 34(9):1565-70. PubMed ID: 8355077
[TBL] [Abstract][Full Text] [Related]
17. Catabolism of 4-fluoro-3-iodobenzylguanidine and meta-iodobenzylguanidine by SK-N-SH neuroblastoma cells.
Vaidyanathan G; Affleck DJ; Alston KL; Welsh P; Zalutsky MR
Nucl Med Commun; 2004 Sep; 25(9):947-55. PubMed ID: 15319601
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of m-iodobenzylguanidine by neuroblastoma cells results from independent uptake and storage mechanisms.
Montaldo PG; Lanciotti M; Casalaro A; Cornaglia-Ferraris P; Ponzoni M
Cancer Res; 1991 Aug; 51(16):4342-6. PubMed ID: 1868458
[TBL] [Abstract][Full Text] [Related]
19. Meta-iodobenzylguanidine derivatives containing a second guanidine moiety.
Vaidyanathan G; Shankar S; Affleck DJ; Alston K; Norman J; Welsh P; LeGrand H; Zalutsky MR
Bioorg Med Chem; 2004 Apr; 12(7):1649-56. PubMed ID: 15028258
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity of alpha-particle-emitting m-[211At]astatobenzylguanidine on human neuroblastoma cells.
Strickland DK; Vaidyanathan G; Zalutsky MR
Cancer Res; 1994 Oct; 54(20):5414-9. PubMed ID: 7923174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
